Beyond the prescription: Medication monitoring and adverse drug events in older adults

Journal of the American Geriatrics Society

Volumn 59, Issue 8, 2011, Pages 1513-1520

  Steinman, Michael A ^a,b   Handler, Steven M ^c,d   Gurwitz, Jerry H ^e,f   Schiff, Gordon D ^g   Covinsky, Kenneth E ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^g BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adverse drug events; aged; drug monitoring

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; DIGOXIN; DIPHENHYDRAMINE; INSULIN; PENICILLIN G; VALPROIC ACID; WARFARIN;

ADVERSE DRUG REACTION; ARTICLE; BLEEDING; CLINICAL PRACTICE; CONCEPTUAL FRAMEWORK; DRUG MONITORING; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INFORMATION TECHNOLOGY; INSOMNIA; KIDNEY FUNCTION; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MORBIDITY; MORTALITY; PATIENT CARE; PHARMACY; PRESCRIPTION; PROSPECTIVE STUDY; QUALITY CONTROL; RISK ASSESSMENT; TEAMWORK;

ACCIDENTAL FALLS; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; ANGIOEDEMA; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DRUG MONITORING; GUIDELINE ADHERENCE; HIP FRACTURES; HUMANS; HYPERKALEMIA; HYPERTENSION; HYPOTENSION, ORTHOSTATIC; INAPPROPRIATE PRESCRIBING; MALE; PATIENT EDUCATION AS TOPIC; PRESCRIPTION DRUGS; RISK ASSESSMENT;

EID: 80051796834     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2011.03500.x     Document Type: Article

References (50)

1. Hanlon JT, Schmader KE, Ruby CM, et al,. Suboptimal prescribing in older inpatients and outpatients. J Am Geriatr Soc 2001; 49: 200-209. (Pubitemid 32207229)
2. Roden DM., Principles of clinical pharmacology. In:, Fauci AS, Braunwald E, Kasper DL, et al., editors. Harrison's Principles of Internal Medicine Online Edition. New York: McGraw Hill. Available at Accessed April 19, 2010.
3. Hilmer SN, Ford GA., General principles of pharmacology. In:, Halter JB, Ouslander JG, Tinetti ME, et al., editors. Hazzard's Geriatric Medicine and Gerontology, Version 6e. New York: McGraw-Hill. Available at Accessed April 19, 2010.
4. Semla TP, Rochon PA, Pharmacotherapy. In:, Pompei P, editor. Geriatrics Review Syllabus: A Core Curriculum in Geriatric Medicine. New York: American Geriatrics Society, 2003, pp 37-44.
5. Avorn J., Improving drug use in elderly patients: Getting to the next level. JAMA 2001; 286: 2866-2868. (Pubitemid 33126931)
6. Gurwitz JH, Field TS, Harrold LR, et al,. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA 2003; 289: 1107-1116. (Pubitemid 37430324)
7. Gandhi TK, Weingart SN, Borus J, et al,. Adverse drug events in ambulatory care. N Engl J Med 2003; 348: 1556-1564. (Pubitemid 36437933)
8. Thomsen LA, Winterstein AG, Sondergaard B, et al,. Systematic review of the incidence and characteristics of preventable adverse drug events in ambulatory care. Ann Pharmacother 2007; 41: 1411-1426. (Pubitemid 47311361)
9. Budnitz DS, Shehab N, Kegler SR, et al,. Medication use leading to emergency department visits for adverse drug events in older adults. Ann Intern Med 2007; 147: 755-765. (Pubitemid 351664440)
10. Samsa GP, Matchar DB., Relationship between test frequency and outcomes of anticoagulation: A literature review and commentary with implications for the design of randomized trials of patient self-management. J Thromb Thrombolysis 2000; 9: 283-292. (Pubitemid 30201262)
11. Budnitz DS, Pollock DA, Weidenbach KN, et al,. National surveillance of emergency department visits for outpatient adverse drug events. JAMA 2006; 296: 1858-1866. (Pubitemid 44596195)
12. Forster AJ, Murff HJ, Peterson JF, et al,. Adverse drug events occurring following hospital discharge. J Gen Intern Med 2005; 20: 317-323. (Pubitemid 40617599)
13. Forster AJ, Clark HD, Menard A, et al,. Adverse events among medical patients after discharge from hospital. Can Med Assoc J 2004; 170: 345-349. (Pubitemid 38223452)
14. Forster AJ, Murff HJ, Peterson JF, et al,. The incidence and severity of adverse events affecting patients after discharge from the hospital. Ann Intern Med 2003; 138: 161-167. (Pubitemid 36231621)
15. Coleman JJ, Ferner RE, Evans SJ., Monitoring for adverse drug reactions. Br J Clin Pharmacol 2006; 61: 371-378.
16. Glasziou P, Irwig L, Mant D., Monitoring in chronic disease: A rational approach. BMJ 2005; 330: 644-648. (Pubitemid 40444763)
17. Poon EG, Gandhi TK, Sequist TD, et al,. "I wish I had seen this test result earlier!": Dissatisfaction with test result management systems in primary care. Arch Intern Med 2004; 164: 2223-2228. (Pubitemid 39452982)
18. Shirts BH, Perera S, Hanlon JT, et al,. Provider management of and satisfaction with laboratory testing in the nursing home setting: Results of a national internet-based survey. J Am Med Dir Assoc 2009; 10: 161-166 e163.
19. Raebel MA, McClure DL, Simon SR, et al,. Laboratory monitoring of potassium and creatinine in ambulatory patients receiving angiotensin converting enzyme inhibitors and angiotensin receptor blockers. Pharmacoepidemiol Drug Saf 2007; 16: 55-64. (Pubitemid 46164976)
20. Raebel MA, Lyons EE, Andrade SE, et al,. Laboratory monitoring of drugs at initiation of therapy in ambulatory care. J Gen Intern Med 2005; 20: 1120-1126. (Pubitemid 43110262)
21. Hurley JS, Roberts M, Solberg LI, et al,. Laboratory safety monitoring of chronic medications in ambulatory care settings. J Gen Intern Med 2005; 20: 331-333. (Pubitemid 40617601)
22. Marcus SC, Olfson M, Pincus HA, et al,. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder. Am J Psychiatry 1999; 156: 1014-1018. (Pubitemid 29302792)
23. Higashi T, Shekelle PG, Solomon DH, et al,. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med 2004; 140: 714-720.
24. Tjia J, Field TS, Garber LD, et al,. Development and pilot testing of guidelines to monitor high-risk medications in the ambulatory setting. Am J Manage Care 2010; 16: 489-496.
25. Handler SM, Hanlon JT, Perera S, et al,. Consensus list of signals to detect potential adverse drug reactions in nursing homes. J Am Geriatr Soc 2008; 56: 808-815. (Pubitemid 351652401)
26. Pirmohamed M, Ferner RE., Monitoring drug treatment. BMJ 2003; 327: 1179-1181. (Pubitemid 37465199)
27. Weingart SN, Gandhi TK, Seger AC, et al,. Patient-reported medication symptoms in primary care. Arch Intern Med 2005; 165: 234-240.
28. Richard C, Lussier MT., Nature and frequency of exchanges on medications during primary care encounters. Patient Educ Couns 2006; 64: 207-216. (Pubitemid 44810861)
29. Sleath B, Roter D, Chewning B, et al,. Asking questions about medication: Analysis of physician-patient interactions and physician perceptions. Med Care 1999; 37: 1169-1173.
30. Gandhi TK, Burstin HR, Cook EF, et al,. Drug complications in outpatients. J Gen Intern Med 2000; 15: 149-154. (Pubitemid 30155346)
31. Rochon PA, Gurwitz JH., Optimising drug treatment for elderly people: The prescribing cascade. BMJ 1997; 315: 1096-1099. (Pubitemid 27458409)
32. Budnitz DS, Layde PM., Outpatient drug safety: New steps in an old direction. Pharmacoepidemiol Drug Saf 2007; 16: 160-165.
33. Cohen HJ, Feussner JR, Weinberger M, et al,. A controlled trial of inpatient and outpatient geriatric evaluation and management. N Engl J Med 2002; 346: 905-912. (Pubitemid 34984640)
34. Ma J, Berra K, Haskell WL, et al,. Case management to reduce risk of cardiovascular disease in a county health care system. Arch Intern Med 2009; 169: 1988-1995.
35. Boohaker EA, Ward RE, Uman JE, et al,. Patient notification and follow-up of abnormal test results. A physician survey. Arch Intern Med 1996; 156: 327-331. (Pubitemid 26058485)
36. Schiff GD, Klass D, Peterson J, et al,. Linking laboratory and pharmacy: Opportunities for reducing errors and improving care. Arch Intern Med 2003; 163: 893-900. (Pubitemid 36519735)
37. Schiff GD, Aggarwal HC, Kumar S, et al,. Prescribing potassium despite hyperkalemia: Medication errors uncovered by linking laboratory and pharmacy information systems. Am J Med 2000; 109: 494-497.
38. Hayward GL, Parnes AJ, Simon SR., Using health information technology to improve drug monitoring: A systematic review. Pharmacoepidemiol Drug Saf 2009; 18: 1232-1237.
39. Blumenthal D, Tavenner M., The "meaningful use" regulation for electronic health records. N Engl J Med 2010; 363: 501-504.
40. Feldstein AC, Smith DH, Perrin N, et al,. Improved therapeutic monitoring with several interventions: A randomized trial. Arch Intern Med 2006; 166: 1848-1854. (Pubitemid 44455167)
41. Smith DH, Feldstein AC, Perrin NA, et al,. Improving laboratory monitoring of medications: An economic analysis alongside a clinical trial. Am J Manage Care 2009; 15: 281-289.
42. Raebel MA, Chester EA, Newsom EE, et al,. Randomized trial to improve laboratory safety monitoring of ongoing drug therapy in ambulatory patients. Pharmacotherapy 2006; 26: 619-626. (Pubitemid 43673044)
43. Raebel MA, Lyons EE, Chester EA, et al,. Improving laboratory monitoring at initiation of drug therapy in ambulatory care: A randomized trial. Arch Intern Med 2005; 165: 2395-2401. (Pubitemid 41640852)
44. Coleman EA, Parry C, Chalmers S, et al,. The care transitions intervention: Results of a randomized controlled trial. Arch Intern Med 2006; 166: 1822-1828. (Pubitemid 44455163)
45. Shrank WH, Avorn J., Educating patients about their medications: The potential and limitations of written drug information. Health Aff (Millwood) 2007; 26: 731-740.
46. Tierney WM., Adverse outpatient drug events-a problem and an opportunity. N Engl J Med 2003; 348: 1587-1589. (Pubitemid 36437936)
47. Chrischilles EA, Segar ET, Wallace RB., Self-reported adverse drug reactions and related resource use. A study of community-dwelling persons 65 years of age and older. Ann Intern Med 1992; 117: 634-640.
48. Schiff GD, Galanter WL., Promoting more conservative prescribing. JAMA 2009; 301: 865-867.
49. Schnipper JL, Kirwin JL, Cotugno MC, et al,. Role of pharmacist counseling in preventing adverse drug events after hospitalization. Arch Intern Med 2006; 166: 565-571.
50. Pindolia VK, Stebelsky L, Romain TM, et al,. Mitigation of medication mishaps via medication therapy management. Ann Pharmacother 2009; 43: 611-620.